SQUIZZATOA,KELLERT,ROMUALDIE,et al.Clopi-dogrel plus aspirin versus aspirin alone for preventing cardiovascular disease[J].Cochrane Database Syst Rev,2011,19(1):CD005158.
[本文引用:1]
[2]
BHATTDL,SCHEIMANJ,ABRAHAMNS,et al.ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents[J].,2008,118(18):1894-1909.
HO PM,MADDOX TM,WANGL,et al.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome[J].,2009,301(9):937-944.
[本文引用:1]
[5]
JUURLINK DN,COMEST,KO DT,et al.A population-based study of the drug interaction between proton pump inhibitors and clopidogrel[J].,2009,180(7):713-718.
[本文引用:1]
[6]
ABRAHAM NS,HLATKY MA,ANTMAN EM,et al.ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use[J].,2010,56(24):2051-2066.
US Food and Drug Administration(FDA).Safety Alerts for Human Medical Products /Clopidogrel(marketed as Plavix) and Omeprazole(marketed as Prilosec) - Drug Interaction[EB/OL].[2009-11-17/]..
US Food and Drug Administration(FDA).drug Safety and Availability/FDA reminder to avoid concomitant use of Plavix(clopidogrel) and omeprazole[EB/OL].[2010- 10-27]..
The European Medicines Agency(EMA) .Public statement on interaction between clopidogrel and proton-pump inhibitors/CHMP updates warning for clopidogrel-containing medicines[EB/OL].[ 2010-03-17]..
WEDEMEYER RS,BLUMEH.Pharmacokinetic drug inte-raction profiles of proton pump inhibitors:an update[J].,2014,37(4):201-211.
[本文引用:3]
[13]
LI XQ,ANDERSSON TB,AHLSTRIJMM,et al.Com-parison of inhibitory effects of the proton pump-inhibiting drugs omeprazole,esomeprazole,lansoprazole,pantoprazole,and rabeprasole on human cytochrome P450 activities[J].,2004,32(8):821-827.
[本文引用:5]
[14]
杨宝峰,苏定冯,周宏灏.[M].7版.北京:人民卫生出版社,2009:324-326.
[本文引用:4]
[15]
李家泰. [M].3版.北京:人民卫生出版社,2007:1820-1828.
[本文引用:4]
[16]
FONTES-CARVALHOR,ALBUQUERQUEA,ARAUJOC,et al.Omeprazole,but not pantoprazole,reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction[J].,2011,23(5):396-404.
[本文引用:1]
[17]
GAGLIA M AJR,TORGUSONR,HANNAN,et al.Rela-tion of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes[J].,2010,105(6):833-838.
[本文引用:1]
[18]
JOHNSON DA,CHILTONR,LIKER HR.Proton-pump inhibitors in patients requiring antiplatelet therapy:new FDA labeling[J].,2014,126(3):239-245.
BHURKE SM,MARTIN BC,LIC,et al.Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome[J].,2012,32(9):809-818.
[本文引用:2]
[21]
SIRISWANGVATS,SANSANAYUDHN,NATHISUWANS,et al.Comparison between the effect of omeprazole and rabeprazole on the antiplatelet action of clopidogrel[J].,2010,74(10):2187-2192.
[本文引用:1]
[22]
EL-HALABI MM,ZGHEIBN,MANSOUR NM,et al.CYP2C19 genetic polymorphism,rabeprazole and esomeprazole have no effect on the antiplatelet action of clopidogrel[J].,2013,62(1):41-49.
[本文引用:1]
[23]
ARBELY,BIRATI EY,FINKELSTEINA,et al.Platelet inhibitory effect of clopidogrel in patients treated with omeprazole,pantoprazole,and famotidine:a prospective,randomized,crossover study[J].,2013,36(6):342-346.
[本文引用:1]
[24]
SHIS,KLOTZU.Proton pump inhibitors:an update of their clinical use and pharmacokinetics[J].,2008,64(10):935-951.
[本文引用:1]
[25]
FERNANDOH,BASSLERN,HABERSBERGERJ,et al.Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel[J].,2011,9(8):1582-1589.
[本文引用:1]
[26]
CHOH,CHOI MK,CHO DY,et al.Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor,ilaprazole[J].,2012,52(7):976-984.
[本文引用:1]
[27]
SHENG-WEN WS,TSAI SS,HSU PC,et al.Concomitant use of clopidogrel and proton pump inhibitors or cimetidine after acute myocardial infarction would increase the risk of re-infarction[J].,2009,104(12):3116-3117.
[本文引用:1]
[28]
SMALL DS,FARID NA,LI YG,et al.Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel[J].,2008,24(8):2251-2257.
HAGIWARAT,KATOM,ANBOT,et al.Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection[J].,2007,13(28):3836-3840.
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines:a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use
US Food and Drug Administration(FDA).Safety Alerts for Human Medical Products /Clopidogrel(marketed as Plavix) and Omeprazole(marketed as Prilosec) - Drug Interaction
US Food and Drug Administration(FDA).drug Safety and Availability/FDA reminder to avoid concomitant use of Plavix(clopidogrel) and omeprazole
0
The European Medicines Agency(EMA) .Public statement on interaction between clopidogrel and proton-pump inhibitors/CHMP updates warning for clopidogrel-containing medicines
Com-parison of inhibitory effects of the proton pump-inhibiting drugs omeprazole,esomeprazole,lansoprazole,pantoprazole,and rabeprasole on human cytochrome P450 activities
Omeprazole,but not pantoprazole,reduces the antiplatelet effect of clopidogrel: a randomized clinical crossover trial in patients after myocardial infarction evaluating the clopidogrel-PPIs drug interaction